Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. / Vestergaard, H; Bjørbaek, C; Andersen, P H; Bak, J F; Pedersen, O.
I: Diabetes, Bind 40, Nr. 12, 12.1991, s. 1740-5.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients
AU - Vestergaard, H
AU - Bjørbaek, C
AU - Andersen, P H
AU - Bak, J F
AU - Pedersen, O
PY - 1991/12
Y1 - 1991/12
N2 - Based on recent studies of the abnormal physiology and biochemistry of the glycogen synthesis in skeletal muscle of non-insulin-dependent diabetes mellitus (NIDDM) patients and their first-degree relatives, the key enzyme of this pathway, glycogen synthase (GS), is considered a candidate gene in the pathogenesis of insulin resistance. Comparing matched groups of 14 NIDDM patients with 14 control subjects, we found that impaired insulin-stimulated nonoxidative glucose metabolism of peripheral tissue (P less than 0.02) and reduced total GS activity (P less than 0.05) of vastus lateralis muscle from patients with NIDDM were accompanied by a 39% reduction (P less than 0.02) in the steady state level of GS mRNA per microgram DNA of muscle. In both diabetic and control subjects, the mRNA expression of GS was unaffected after euglycemic-hyperinsulinemic clamp for 4 h. With single-stranded conformation polymorphism analysis of the entire coding sequence of the GS gene, we were unable to detect any genetic variants in a subset of eight NIDDM patients. We conclude that abnormal pretranslational regulation of the GS gene may contribute to impaired glycogen synthesis of muscle in NIDDM. Our studies give no evidence for structural changes in the coding region of the GS gene, and it is unknown if the decreased mRNA expression is due to impaired transcription or accelerated degradation of the transcript.
AB - Based on recent studies of the abnormal physiology and biochemistry of the glycogen synthesis in skeletal muscle of non-insulin-dependent diabetes mellitus (NIDDM) patients and their first-degree relatives, the key enzyme of this pathway, glycogen synthase (GS), is considered a candidate gene in the pathogenesis of insulin resistance. Comparing matched groups of 14 NIDDM patients with 14 control subjects, we found that impaired insulin-stimulated nonoxidative glucose metabolism of peripheral tissue (P less than 0.02) and reduced total GS activity (P less than 0.05) of vastus lateralis muscle from patients with NIDDM were accompanied by a 39% reduction (P less than 0.02) in the steady state level of GS mRNA per microgram DNA of muscle. In both diabetic and control subjects, the mRNA expression of GS was unaffected after euglycemic-hyperinsulinemic clamp for 4 h. With single-stranded conformation polymorphism analysis of the entire coding sequence of the GS gene, we were unable to detect any genetic variants in a subset of eight NIDDM patients. We conclude that abnormal pretranslational regulation of the GS gene may contribute to impaired glycogen synthesis of muscle in NIDDM. Our studies give no evidence for structural changes in the coding region of the GS gene, and it is unknown if the decreased mRNA expression is due to impaired transcription or accelerated degradation of the transcript.
KW - Blotting, Northern
KW - DNA
KW - Diabetes Mellitus, Type 2
KW - Female
KW - Gene Expression Regulation, Enzymologic
KW - Glucose Clamp Technique
KW - Glycogen Synthase
KW - Humans
KW - Insulin
KW - Insulin Infusion Systems
KW - Male
KW - Middle Aged
KW - Muscles
KW - Polymorphism, Genetic
KW - RNA, Messenger
KW - Reference Values
M3 - Journal article
C2 - 1756915
VL - 40
SP - 1740
EP - 1745
JO - Diabetes
JF - Diabetes
SN - 0012-1797
IS - 12
ER -
ID: 92194274